DE ICCO, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.115
AS - Asia 2.973
EU - Europa 1.819
SA - Sud America 536
AF - Africa 180
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.628
Nazione #
US - Stati Uniti d'America 3.019
CN - Cina 968
SG - Singapore 787
IE - Irlanda 416
BR - Brasile 408
HK - Hong Kong 401
VN - Vietnam 397
RU - Federazione Russa 354
DE - Germania 232
IT - Italia 196
FR - Francia 160
FI - Finlandia 124
GB - Regno Unito 124
ZA - Sudafrica 104
IN - India 94
BD - Bangladesh 50
CA - Canada 45
AR - Argentina 41
IQ - Iraq 34
JP - Giappone 34
MX - Messico 34
ID - Indonesia 30
PL - Polonia 28
AT - Austria 26
NL - Olanda 24
SE - Svezia 24
ES - Italia 23
TR - Turchia 23
CO - Colombia 22
MA - Marocco 21
PK - Pakistan 21
EC - Ecuador 20
PH - Filippine 15
BE - Belgio 14
UZ - Uzbekistan 14
SA - Arabia Saudita 13
IR - Iran 12
CL - Cile 11
CZ - Repubblica Ceca 10
DZ - Algeria 10
VE - Venezuela 10
EG - Egitto 9
MY - Malesia 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
KE - Kenya 8
LT - Lituania 8
PE - Perù 8
PY - Paraguay 8
GR - Grecia 7
IL - Israele 7
AL - Albania 6
ET - Etiopia 6
JO - Giordania 6
UA - Ucraina 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
NP - Nepal 5
PT - Portogallo 5
KZ - Kazakistan 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
TH - Thailandia 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
JM - Giamaica 3
KH - Cambogia 3
LB - Libano 3
QA - Qatar 3
RO - Romania 3
SN - Senegal 3
YE - Yemen 3
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
HR - Croazia 2
HU - Ungheria 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
GF - Guiana Francese 1
GN - Guinea 1
GT - Guatemala 1
LR - Liberia 1
ME - Montenegro 1
MM - Myanmar 1
Totale 8.620
Città #
Singapore 426
Dublin 415
Hong Kong 386
San Jose 380
Chandler 369
Ashburn 345
Dallas 262
Beijing 259
Ho Chi Minh City 133
Lauterbourg 115
Boardman 108
Los Angeles 106
Munich 96
Nanjing 92
Johannesburg 89
Hanoi 81
New York 78
Helsinki 72
Redondo Beach 71
Lawrence 64
Princeton 64
Medford 63
Shanghai 63
Moscow 59
Nanchang 50
Milan 49
São Paulo 49
Changsha 41
Turku 41
Buffalo 40
Hebei 39
Shenyang 36
Santa Clara 33
Frankfurt am Main 30
Wilmington 29
Falkenstein 28
Orem 27
Tokyo 27
Jacksonville 26
Jiaxing 26
Haiphong 24
Hangzhou 24
The Dalles 24
Warsaw 23
Poplar 21
Chennai 20
Chicago 20
London 19
Atlanta 18
Columbus 18
Mexico City 18
Seattle 18
Brooklyn 17
Da Nang 17
Montreal 17
Rome 17
Manchester 16
Nuremberg 16
Stockholm 15
Tianjin 15
Amsterdam 14
Brussels 14
Denver 14
Rio de Janeiro 14
Fairfield 13
Houston 13
Tashkent 13
Toronto 13
Baghdad 12
Phoenix 12
Guayaquil 11
Mumbai 11
Norwalk 11
Biên Hòa 10
Guangzhou 10
Ann Arbor 9
Belo Horizonte 9
Brasília 9
Dhaka 9
Pavia 9
San Francisco 9
Boston 8
Campinas 8
Düsseldorf 8
Nairobi 8
Vienna 8
Cairo 7
Dearborn 7
Lahore 7
Medellín 7
Addis Ababa 6
Amman 6
Ankara 6
Athens 6
Bến Tre 6
Can Tho 6
Cape Town 6
Casablanca 6
Council Bluffs 6
Falls Church 6
Totale 5.511
Nome #
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 148
Circadian phase typing in idiopathic generalized epilepsy: Dim light melatonin onset and patterns of melatonin secretion—Semicurve findings in adult patients 132
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm 129
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study 124
Acute effects of high-frequency microfocal vibratory stimulation on the H reflex of the soleus muscle. A double-blind study in healthy subjects 121
Time for a consensus conference on pain in neurorehabilitation 120
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 119
Intra- and Extracranial MR Venography: Technical Notes, Clinical Application, and Imaging Development 117
TRANSCRANIAL DIRECT CURRENT STIMULATION (t-DCS) AS ADD-ON TO NEUROREHABILITATION OF PISA SYNDROME IN PARKINSON’S DISEASE: A RANDOMIZED CONTROLLED TRIAL 117
Anodal transcranial direct current stimulation and intermittent theta-burst stimulation improve deglutition and swallowing reproducibility in elderly patients with dysphagia 115
Chronotype in patients with epilepsy: A controlled study in 60 subjects with late-onset focal epilepsy 114
Bedside Vestibular Examination 113
Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study 111
Acute and Chronic Effect of Acoustic and Visual Cues on Gait Training in Parkinson's Disease: A Randomized, Controlled Study 111
Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial 110
Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project 109
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 109
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 108
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 101
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 100
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 100
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine 100
Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy 99
Expression of selected microRNAs in migraine: A new class of possible biomarkers of disease? 99
Nerve Fascicles and Epineurium Volume Segmentation of Peripheral Nerve Using Magnetic Resonance Micro-neurography 98
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 96
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 96
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 94
The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment 92
Ability of a set of trunk inertial indexes of gait to identify gait instability and recurrent fallers in parkinson’s disease 92
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings 90
Clinical Subtypes of Medication Overuse Headache - Findings From a Large Cohort 90
Onabotulinumtoxina reduces temporal pain processing at spinal level in patients with lower limb spasticity 90
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia 89
Social Jet Lag in epilepsy: its entity and features in a clinical series of adult patients 88
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 86
Healthcare practitioners and robotic-assisted rehabilitation: understanding needs and barriers 85
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 85
Botulinum toxin is effective in the management of neurogenic dysphagia. clinical-electrophysiological findings and tips on safety in different neurological disorders 85
Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back 85
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 85
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 83
The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study 82
Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson’s disease: a multicenter randomized controlled trial 81
Specific patterns of laryngeal electromyography during wakefulness are associated to sleep disordered breathing and nocturnal stridor in multiple system atrophy 81
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 80
Falls, fractures and bone density in Parkinson’s disease–a cross-sectional study 80
Migraine neuroscience: from experimental models to target therapy 80
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences 79
Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorder 79
Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events 78
Experimentally-induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study 77
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 76
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 76
Gender Differences in the Clinical Presentation of Cluster Headache: A Role for Sexual Hormones? 76
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 74
Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity 73
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks 72
The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain 72
Intracranial Nonstenosing Atherosclerotic Plaques Assessed With Vessel Wall MRI in Patients With Embolic Stroke of Undetermined Source 71
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 68
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study 68
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 67
Multiscale Entropy Algorithms to Analyze Complexity and Variability of Trunk Accelerations Time Series in Subjects with Parkinson’s Disease 66
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 64
Harmonic ratio is the most responsive trunk-acceleration derived gait index to rehabilitation in people with Parkinson’s disease at moderate disease stages 63
Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study 63
Effects of home-based virtual reality telerehabilitation system in people with multiple sclerosis: A randomized controlled trial 62
Efficacy of non-immersive virtual reality-based telerehabilitation on postural stability in Parkinson's disease: a multicenter randomized controlled trial 61
Getting closer to a cure for migraine 61
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine? 61
Headache in 2021: clinical, biological, and genetic advances 61
Electrophysiological evidence of subclinical trigeminal dysfunction in patients with COVID-19 and smell impairment: A pilot study 59
From DYMUS to DYPARK: Validation of a Screening Questionnaire for Dysphagia in Parkinson’s Disease 59
Pearls & Oy-sters: Marionette Walk in Parkinson Disease 58
Theory of mind in chronic migraine with medication overuse assessed with the MASC 57
Exploring the neural and behavioral correlates of cognitive telerehabilitation in mild cognitive impairment with three distinct approaches 56
Non-invasive Brain and Spinal Stimulation for Pain and Related Symptoms in Multiple Sclerosis: A Systematic Review 56
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches 56
Social cognition in chronic migraine with medication overuse: a cross-sectional study on different aspects of mentalization and social relationships 55
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 55
Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes 55
Effects of home-based virtual reality telerehabilitation system in people with multiple sclerosis: A randomized controlled trial 55
Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis 54
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 54
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review 53
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 52
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 52
Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches 50
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 50
Redefining migraine prevention: Early treatment with anti-CGRP monoclonal antibodies enhances response in the real world 50
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 50
Electrical stimulation of injected muscles to boost botulinum toxin effect on spasticity: Rationale, systematic review and state of the art 50
Triggers of migraine: where do we stand? 49
Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project 48
Role of Estrogens in Menstrual Migraine 48
Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial 48
Dissecting out migraine complexity through comprehensive analysis of allodynia 47
Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study 47
Relationship between lumbar lordosis, pelvic parameters, PI-LL mismatch and outcome after short fusion surgery for lumbar degenerative disease. Literature review, rational and presentation of public study protocol: RELApSE study (registry for evaluation of lumbar artrodesis sagittal alignEment) 46
Totale 7.956
Categoria #
all - tutte 37.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 17 0 2
2021/2022250 1 0 6 1 3 6 2 24 13 6 36 152
2022/20231.029 112 84 18 85 82 83 1 53 469 8 27 7
2023/2024496 71 54 20 37 40 92 26 45 9 17 28 57
2024/20252.055 57 96 37 24 38 263 170 103 492 99 245 431
2025/20264.415 433 325 460 511 603 178 842 263 506 294 0 0
Totale 8.871